Fulvestrant plus capivasertib for metastatic breast cancer - Authors' reply

Lancet Oncol. 2020 May;21(5):e234. doi: 10.1016/S1470-2045(20)30237-0.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aromatase Inhibitors
  • Aromatase*
  • Estrogens
  • Fulvestrant*
  • Humans
  • Neoplasm Recurrence, Local

Substances

  • Aromatase Inhibitors
  • Estrogens
  • Fulvestrant
  • Aromatase